The rule to mandate the use of MedDRA has been published
in the Federal Register for comment.
Companies can license MedDRA from an international maintenance
and support services organization (MSSO) (toll free number 877-258-8280, fax 703-345-7791, e-mail
mssosubscribe@ngc.com, Internet
at www.meddramsso.com.
The documents mentioned above may be found on the FDA web site
at the following addresses:
http://www.fda.gov/OHRMS/DOCKETS/98fr/03-5204.pdf
http://www.fda.gov/oc/initiatives/barcode-sadr
|
